Immunoediting in acute myeloid leukemia: Reappraising T cell exhaustion and the aberrant antigen processing machinery in leukemogenesis

Ching-Yun Wang; Shiuan-Chen Lin; Kao-Jung Chang; Han-Ping Cheong; Sin-Rong Wu; Cheng-Hao Lee; Ming-Wei Chuang; Shih-Hwa Chiou; Chih-Hung Hsu; Po-Shen Ko

Heliyon (Nov 2024)

Immunoediting in acute myeloid leukemia: Reappraising T cell exhaustion and the aberrant antigen processing machinery in leukemogenesis

Ching-Yun Wang,
Shiuan-Chen Lin,
Kao-Jung Chang,
Han-Ping Cheong,
Sin-Rong Wu,
Cheng-Hao Lee,
Ming-Wei Chuang,
Shih-Hwa Chiou,
Chih-Hung Hsu,
Po-Shen Ko

Affiliations

Ching-Yun Wang: Department of Medical Education, Taichung Veterans General Hospital, Taichung, Taiwan
Shiuan-Chen Lin: School of Medicine, National Yang-Ming Chiao Tung University, Taipei, Taiwan; Department of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan
Kao-Jung Chang: School of Medicine, National Yang-Ming Chiao Tung University, Taipei, Taiwan; Department of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan; Institute of Clinical Medicine, National Yang-Ming Chiao Tung University, Taipei, Taiwan; Department of Ophthalmology, Taipei Veterans General Hospital, Taipei, Taiwan
Han-Ping Cheong: Department of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan; Institute of Pharmacology, National Yang-Ming Chiao Tung University, Taipei, Taiwan
Sin-Rong Wu: Department of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan
Cheng-Hao Lee: Department of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan
Ming-Wei Chuang: Department of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan
Shih-Hwa Chiou: School of Medicine, National Yang-Ming Chiao Tung University, Taipei, Taiwan; Department of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan; Institute of Clinical Medicine, National Yang-Ming Chiao Tung University, Taipei, Taiwan; Department of Ophthalmology, Taipei Veterans General Hospital, Taipei, Taiwan; Institute of Pharmacology, National Yang-Ming Chiao Tung University, Taipei, Taiwan; Genomic Research Center, Academia Sinica, Taipei, Taiwan
Chih-Hung Hsu: Department of Environmental Medicine, Zhejiang University School of Medicine, Hangzhou, 310006, China; Corresponding author, Department of Environmental Medicine, Zhejiang University School of Medicine, China
Po-Shen Ko: School of Medicine, National Yang-Ming Chiao Tung University, Taipei, Taiwan; Division of Hematology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; Corresponding author, Division of Hematology, Department of Medicine, Taipei Veterans General Hospital, Taiwan

Journal volume & issue: Vol. 10, no. 21
p. e39731

Abstract

Read online

Acute myeloid leukemia (AML) establishes an immunosuppressive microenvironment that favors leukemic proliferation. The immune-suppressive cytokines altered antigen processing, and presentation collectively assist AML cells in escaping cytotoxic T-cell surveillance. These CD8+ T cell dysfunction features are emerging therapeutic targets in relapsed/refractory AML patients. Besides, CD8+ T cell exhaustion is a hotspot in recent clinical oncology studies, but its pathophysiology has yet to be elucidated in AML. In this review, we summarize high-quality original studies encompassing the phenotypic and genomic characteristics of T cell exhaustion events in the leukemia progression, emphasize the surface immuno-peptidome that dynamically tunes the fate of T cells to function or dysfunction states, and revisit the biochemical and biophysical properties of type 1 MHC antigen processing mechanism (APM) that pivots in the phenomenon of leukemia antigen dampening.

Published in Heliyon

ISSN: 2405-8440 (Online)
Publisher: Elsevier
Country of publisher: United Kingdom
LCC subjects: Science: Science (General); Social Sciences: Social sciences (General)
Website: https://www.cell.com/heliyon/home

About the journal